Impact BioMedical Inc. (IBO) financial statements and ratios from SEC XBRL: revenue $32000.00 (TTM), net margin -36993.8%, revenue growth -57.1% YoY, P/E 65.6. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $32000.00 |
| Net Margin | -36993.8% |
| Revenue Growth (YoY) | -57.1% |
| EPS Growth (YoY) | -99.2% |
| P/E Ratio | 65.6 |
| Price / Book | 3.69 |
| Price / Sales | 1617.32 |
| Altman Z-Score | 11.94 (safe) |
| Sector P/E (Healthcare) | 21.7 |
IBO overview · IBO earnings · IBO KPIs · IBO investor relations · IBO ownership · IBO peers · IBO filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.